Flow injection spectrophotometric determination of adrenaline in pharmaceutical formulations using a solid-phase reactor containing lead(IV) dioxide immobilized in a polyester resin.
A flow injection spectrophotometric procedure is proposed for determining adrenaline in pharmaceutical formulations. In this work, the adrenaline in acetate buffer reacts with a solid-phase reactor containing lead(IV) dioxide immobilized in a polyester resin and the adrenochrome yielded was continuously monitored at 486 nm. The analytical curve was linear in the adrenaline concentration range from 0.1 to 0.8 mmol l(-1) with a detection limit of 8 x 10(-3) mmol l(-1). Recoveries of 96.5-105% and relative standard deviation of 0.2% for a solution containing 0.4 mmol l(-1) adrenaline (n = 10) were obtained. The analytical frequency was 130 determinations per hour and the results obtained for adrenaline in pharmaceutical formulations using this procedure and those obtained using a pharmacopoeia procedure are in agreement at the 95% confidence level.